Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Giulia Marrone

Biographic Data

ID7896218
NAMEGiulia Marrone
GIVEN NAMESGiulia
FAMILY NAMEMarrone
SIGNATUREMARRONE G
AFFILIATIONSUniversity of Rome Tor Vergata
ORCID0000-0002-5854-2086
VERIFIEDYes
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2022
H-INDEX0
  • The Impact of Functional Bars and Adapted Physical Activity on Quality of Life in Chronic Kidney Disease

    Open Access•Elisa Grazioli, Eliana Tranchita et al.•ARTICLE•International Journal of…•2022

    Chronic kidney disease (CKD) represents a public health problem because it is characterized by several comorbidities, including uremic sarcopenia (US), and a poor quality of life. Currently, there are no standardized treatments available to counteract the onset of US but only some possible therapeutic approaches to slow its progression. The aim of this pilot study is to collect descriptive data in order to design a clinical trial based on the pow…

  • Characterization of Gut Microbiota Composition in Type 2 Diabetes Patients

    Open Access•Isabella Polidori, Laura Marullo et al.•ARTICLE•International Journal of…•2022

    (1) Background: A clinical laboratory index to assess gut dysbiosis is the F/B ratio < 0.8. In fact, an elevated proportion of Firmicutes and a reduced population of Bacteroides in diabetes type 2 (T2D) subjects has been observed. This study aimed to detail the dysbiosis status in the Italian population, focusing on some pathogenic spectra (T2D) or metabolic disorders. (2) Material and methods: A quantity of 334 fecal samples was analyzed in orde…

No prominent works on this page.

  • The Impact of Functional Bars and Adapted Physical Activity on Quality of Life in Chronic Kidney Disease

    Open Access•Elisa Grazioli, Eliana Tranchita et al.•ARTICLE•International Journal of…•2022

    Chronic kidney disease (CKD) represents a public health problem because it is characterized by several comorbidities, including uremic sarcopenia (US), and a poor quality of life. Currently, there are no standardized treatments available to counteract the onset of US but only some possible therapeutic approaches to slow its progression. The aim of this pilot study is to collect descriptive data in order to design a clinical trial based on the pow…

  • Characterization of Gut Microbiota Composition in Type 2 Diabetes Patients

    Open Access•Isabella Polidori, Laura Marullo et al.•ARTICLE•International Journal of…•2022

    (1) Background: A clinical laboratory index to assess gut dysbiosis is the F/B ratio < 0.8. In fact, an elevated proportion of Firmicutes and a reduced population of Bacteroides in diabetes type 2 (T2D) subjects has been observed. This study aimed to detail the dysbiosis status in the Italian population, focusing on some pathogenic spectra (T2D) or metabolic disorders. (2) Material and methods: A quantity of 334 fecal samples was analyzed in orde…

Internal Medicine (2 works) · Medicine (2 works) · Bacteria (1 work) · Bacteroides (1 work) · Bacteroidetes (1 work) · Biology (1 work) · Clinical trial (1 work) · Clostridium difficile and Clostridium perfringens research (1 work) · Diabetes mellitus (1 work) · Dialysis and Renal Disease Management (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae